GIT Conditions 1 1
GIT Conditions 1 1
GIT Conditions 1 1
their Management
1
Intestines
Clinical manifestations include:
• Crohn's disease manifests with intermittent diarrhoea, pain,
weight loss, malaise and sometimes fever
• Depending upon the area of intestine involved, the stool
may contain
occult blood
• Where there is involvement of the upper GIT, symptoms
similar to those of peptic ulcer disease may be experienced
• Malnutrition may be present when the distal small intestine
is involved due to inadequate absorption of nutrients
Management
• Treatment is aimed at reducing inflammation and infection and
alleviating symptoms.
• This is achieved by use of antimicrobial drugs and steroids.
• The patient needs a high calorie, high vitamin, high protein, low
residue and milk free diet.
complications
Perforation,
Fistula Formation
Haemorrhage,
Toxic Megacolon,
Obstruction,
Malabsorption
Susceptibility To Neoplasia
2. Ulcerative Colitis
These include
Diarrhoea,(sterile)
Passage Of Mucus And Pus
Other symptoms include lower abdominal pain and abdominal tenderness,
intermittent tenesmus and rectal bleeding
The patient may also present with fever, anorexia, weight loss, nausea and
vomiting and dehydration
Edematous and inflamed mucosa , and abscsess formation
hypocalcemia , anemia and fatigue frequently develop
Rebound tenderness right lower quantrant
Extra intestinal manifestations: skin lesions e.g. erythemanodosum, eye lesion
e.g. uveitis, joint abnormalities e.g athritis ,and liver disease
Eventually bowel narrows , shortens and thickens because of muscular
hypertrophy and fat deposits
Diagnosis:
• Sigmoidoscopy or colonoscopy -show inflamed mucosa with
ulceration , to define extend and severity of disease
• Barium enema – show mucosal irregularities
• CT scan ,MRI, and ultrasound –identify abscess
• Stool examination to rule out dysentery
Complications
Perforation
toxic mega colon-affects muscles, inhibiting contraction,
causing its distention ,with fever , abdominal pain , vomiting
and fatigue and shock.
Bleeding
cancer
Management
• The patient with mild disease requires:
a low roughage diet,
Fistula in Ano
• This is a tiny tubular tract that extends into the anal canal from an opening
located outside the anus. Fistulectomy is the recommended surgical
procedure for repair of the fistula.
Haemorrhoids
• These are varicose veins in the anal canal. Those occurring above the
internal sphincter are referred to as internal haemorrhoids and those
appearing outside the external sphincter are called external haemorrhoids.
Toxic and drug induced hepatitis are largely managed with support to the
patient in terms of nutrition, rest, fluids and electrolyte monitoring. The
patient with liver cirrhosis needs at least 300 calories in the diet per day.
High carbohydrate intake, low proteins (depending on the stage), low fat
diet, low sodium (for the patient with ascitis) is all indicated.
Clinical Manifestation
• Acute liver damage may be completely reversible or may progress to
cirrhosis whereby the parenchymal cells are replaced with fibrotic
tissue. When the ability of the liver to carry out its excretory and
metabolic function falls below the needs of the body, the patient is
said to be in Liver failure. Hepatic coma results when liver
dysfunction is so severe that the liver is unable to remove end
products of metabolism from the blood stream.
Acute Hepatitis
• This may be a result of viral infection or ingestion of toxic substances.
Viral Infections
• Hepatitis A, ( formally infectious hepatitis ) caused by the Hepatitis A
virus and is transmitted through the fecal oral route. The incubation
period is 15 to 40 days and the viruses are excreted in feaces. More
prevalent in countries with overcrowding and poor sanitation It is
commonly transmitted sexually in homosexual men.
• With infection no carrier states exists ,no chronic hepatitis associated
with HAV and confers immunity against itself.
Acute Hepatitis
• Hepatitis B ( formerly serum hepatitis) is the more serious of the viral
hepatitis. The incubation period is 50 to 180 days. It is spread by blood and
blood products, thus making it common among persons whose occupation
involves contact with blood and blood products and also among
intravenous drug addicts and male homosexuals .HBV is transmitted
through mucous membranes and breaks in the skin. The virus is also
spread by body fluids e.g. saliva, semen, vaginal secretions and from the
mother to the foetus not via the umbilical vein but from mother at time of
birth and contact there after .
• 90% of HBV patients recover in 6/12 .10% progress carrier state or develop
chronic hepatitis with persistent HBV infection and hepatocellular injury
and inflammation.
Acute Hepatitis
• Infection usually leads to severe illness lasting 2 to 6 weeks. On
infection, antibodies are formed and immunity persists after recovery.
Type B virus may cause massive liver necrosis and death. This
condition can result in hepatocellular carcinoma and liver cirrhosis.
• Hepatitis C virus (formerly non A , non B hepatitis) is also spread by
blood and blood products and is therefore prevalent in IV drug
abusers. The infection can be asymptomatic but when hepatitis
develops, it is often recurrent and may result in chronic liver disease.
Other viruses are hepatitis D,E, and G
Acute Hepatitis
non viral hepatitis
• Toxic hepatitis . Certain chemicals have toxic effects on the liver and
produce acute liver cell necrosis ,or toxic hepatitis when
inhaled ,injected parenterally or taken by mouth ie carbon
tetrachloride, phosphorus ,chloroform,and gold compounds .The
extent of the damage usually depends on the dose and duration of
exposure.
• . Alcohol toxicity also causes hepatitis. This occurs after chronic abuse
of alcohol and the symptoms include jaundice, hepatomegally ,
anorexia and malaise.
Acute Hepatitis
non viral hepatitis
Toxic and drug induced hepatitis are largely managed with support to the
patient in terms of nutrition, rest, fluids and electrolyte monitoring. The
patient with liver cirrhosis needs at least 300 calories in the diet per day.
High carbohydrate intake, low proteins (depending on the stage), low fat
diet, low sodium (for the patient with ascites) is all indicated.
Management of Liver Disease -
cont’d
• Should the condition get worse, proteins should be limited to avoid
accumulation of ammonia in the body leading to hepatic
encephalopathy. This particular patient should receive complete bed
rest, diuretics and B-complex vitamins. They should abstain from alcohol
totally.
Clinical features include changes of intellect, personality, emotions and consciousness, with or
without neurological signs. In early stages, features are mild but as the condition becomes more
severe, the patient has inability to concentrate, confusion, disorientation, drowsiness, slurring of
speech and sometimes convulsions. Overt psychosis and convulsions may also occur.
• Episodes of encephalopathy are usually reversible until terminal stages of cirrhosis. In managing
this condition, the aim is to reduce or eliminate protein intake, and to suppress production of
neurotoxins by bacteria in the bowel. Lactulose is also given and it produces an osmotic laxative
effect, reduces the pH of the colonic content thereby limiting colonic ammonia absorption and
promotes the incorporation of nitrogen into the bacteria. Neomycin is also used as it acts by
reducing the bowel flora.
• You should read further on hepatic coma and the hepatorenal syndrome.
Diseases of the Gall Bladder
• The gall bladder is most commonly affected by gallstones
(cholelithiasis) and inflammation (cholecystitis). Gallstones are
formed through precipitation of constituents of bile.
• Abnormal composition of bile, stasis of bile and inflammation of the
gallbladder contribute to the process of precipitation. Gallstones start
manifesting symptoms when they block the ducts. Pain is common.
Factors that predispose to gallstones include:
• Changes in bile composition
• High levels of blood and dietary cholesterol
• Cholecystitis
• Diabetes Mellitus when associated with high blood cholesterol levels
• Haemolytic disease
• Female gender
• Obesity
• Long term use of oral contraceptives
Gallstones – cont’d
• Diagnosis of gallstones is by
ultrasonography, cholecystography
and percutaneous Transhepatic
Cholangiography.
• Complications of cholelithiasis
include biliary colic, inflammation
and inpaction.
• Cholelithiasis commonly occurs
together with cholecystitis. The
manifestations of cholecystitis
include:
Gallstones – signs and symptons
• Intolerance of fatty foods
• Belching
• Vomiting
• Jaundice
• Fever
• Cholecystitis can be acute or
chronic. If chronic, it can
contribute to cancer of the gall
bladder.
Care of the Patient with Gall
Bladder Disease
• The management of an adult with gall bladder disease should start
with a primary assessment. The data will be obtained by finding out
about the clinical presentation of the disease, which has already been
mentioned. In those patients with gall bladder disease, it is advisable
to concentrate on certain goals to be able to achieve desired results.
These goals include:
• Relief of pain and discomfort
• Prevention of complications after surgery
• Prevention of recurrent attacks and maintenance of desired lifestyle
Care of the Patient with Gall
Bladder Disease
• The patient with cholelithiasis (gall stones) may be put either on
conservative or surgical treatment. Conservatively IV fluids, nil per
oral, NG tube feeding, low fat diet, antiemetics, analgesics and fat
soluble vitamins (ADE and K) are used. Anticholinergics, bile salts,
antibiotics and bile acid therapy will benefit the patient. The
Anticholinergics will affect the contraction of the bile duct.
• The surgical management involves cholecystectomy. When one has
cholecystitis, treatment is mainly supportive and symptomatic. For
instance, if nausea and vomiting are severe, gastric decompression is
done to prevent gall bladder stimulation. Anticholinergic and
analgesics may be given to these patients to decrease the pain.
Pancreatitis
• Pancreatitis is an inflammation of the pancreas. Acute pancreatitis is
when the structure and function of the pancreas usually return to
normal after the acute attack.
• Chronic pancreatitis results in permanent abnormalities of pancreatic
function. Acute pancreatitis occurs after digestion of this organ by the
very enzymes it produces, especially trypsin. Other associated causes
of pancreatitis include bacterial or viral infections, blunt abdominal
trauma, ischemic vascular disease and use of drugs such
corticosteroids, oral contraceptives, narcotics and thiazide diuretics.
Management of Pancreatitis
• The patient should therefore minimise physical activity through bed rest, receive a
strong analgesic, nil per oral with NG tube suction, and IV fluids. The use of anti-
cholonergic drugs can decrease pain.
• The patient with chronic pancreatitis requires prevention of attacks and frequent doses
of analgesics. Pancreatic exocrine and endocrine insufficiency should be assessed and
modes of management considered. Diet, pancreatic enzyme replacement and control of
the diabetes are measures used to control the insufficiency. The patient may not
tolerate fatty, rich and stimulating foods and, these must be avoided. You should stress
that the patients avoid alcohol totally. Antacids and anti-cholinergic drugs are given to
decrease hydrochloric acid secretion. Surgery may be used to treat chronic pancreatitis.
Patients who have surgery should have replacement of the hormones.
• Always remember to manage this patient for the potential of development of diabetes
mellitus.
JAUNDICE
• When the bilirubin concentration in the blood is abnormally
• elevated, all the body tissues, including the sclerae and the skin,
• become yellow-tinged or greenish-yellow, a condition called jaundice
Management of Pancreatitis
• The objectives of therapeutic management of acute pancreatitis
include:
• Relief of pain
• Prevention or treatment of shock
• Reduction of pancreatic secretions
• Control of fluids and electrolyte balance
• Prevention and treatment of infection
• Removal of the precipitating cause
• jaundice.
• Jaundice becomes clinically evident when the serum bilirubin
• level exceeds 2.5 mg/dL (43 fmol/L). Increased serum bilirubin levels
• and jaundice may result from impairment of hepatic uptake,
• conjugation of bilirubin, or excretion of bilirubin into the biliary
• system. There are several types of jaundice: hemolytic, hepatocellular,
• obstructive, or jaundice due to hereditary hyperbilirubinemia.
• Hepatocellular and obstructive jaundice are the two types commonly
associated with liver disease
Hemolytic Jaundice
• Hemolytic jaundice is the result of an increased destruction of the
• red blood cells, the effect of which is to flood the plasma with
• bilirubin so rapidly that the liver, although functioning normally,
• cannot excrete the bilirubin as quickly as it is formed. This type
• of jaundice is encountered in patients with hemolytic transfusion
• reactions and other hemolytic disorders. The bilirubin in the blood
• of these patients is predominantly of the unconjugated, or free,
• type. Fecal and urine urobilinogen levels are increased, but the
• urine is free of bilirubin. Patients with this type of jaundice, unless
• their hyperbilirubinemia is extreme, do not experience symptoms
• or complications as a result of the jaundice per se. Prolonged
• jaundice, however, even if mild, predisposes to the formation of
• pigment stones in the gallbladder, and extremely severe jaundice
• (levels of free bilirubin exceeding 20 to 25 mg/dL) poses a risk for brain stem damage
Obstructive Jaundice
• Obstructive jaundice of the extrahepatic type may be caused by
• occlusion of the bile duct by a gallstone, an inflammatory process,
• a tumor, or pressure from an enlarged organ. The obstruction may
• also involve the small bile ducts within the liver (ie, intrahepatic
• obstruction), caused, for example, by pressure on these channels
• from inflammatory swelling of the liver or by an inflammatory
• exudate within the ducts themselves. Intrahepatic obstruction resulting
• from stasis and inspissation (thickening) of bile within the
• canaliculi may occur after the ingestion of certain medications,
Assessment-bulging flanks in supine position
percussion /fluid wave
• Medical Management
• DIETARY MODIFICATION
• The goal of treatment for the patient with ascites is a negative
• sodium balance to reduce fluid retention. Table salt, salty foods,
• salted butter and margarine, and all ordinary canned and frozen
• foods (foods that are not specifically prepared for low-sodium diets)
• should be avoided. It may take 2 to 3 months for the patient’s taste
• buds to adjust to unsalted foods. In the meantime, the taste of unsalted
• foods can be improved by using salt substitutes such as lemon
• juice, oregano, and thyme. Commercial salt substitutes need to be
• approved by the physician because those containing ammonia
• could precipitate hepatic coma. Most salt substitutes contain potassium
Hepatocellular Jaundice
• Hepatocellular jaundice is caused by the inability of damaged
• liver cells to clear normal amounts of bilirubin from the blood.
• The cellular damage may be from infection, such as in viral hepatitis
• (eg, hepatitis A, B, C, D, or E) or other viruses that affect
• the liver (eg, yellow fever virus, Epstein-Barr virus), from medication
• or chemical toxicity (eg, carbon tetrachloride, chloroform,
• phosphorus, arsenicals, certain medications), or from alcohol.
• Cirrhosis of the liver is a form of hepatocellular disease that may
• produce jaundice. It is usually associated with excessive alcohol
• intake, but it may also be a late result of liver cell necrosis caused
• by viral infection. In prolonged obstructive jaundice, cell damage
• eventually develops, so that both types appear together.
• Patients with hepatocellular jaundice may be mildly or severely
• ill, with lack of appetite, nausea, malaise, fatigue, weakness,
• and possible weight loss. In some cases of hepatocellular disease,
• jaundice may not be obvious. The serum bilirubin concentration
• and urine urobilinogen level may be elevated. In addition, AST
• and ALT levels may be increased, indicating cellular necrosis. The
• patient may report headache, chills, and fever if the cause is infectious.
• Depending on the cause and extent of the liver cell
• damage, hepatocellular jaundice may or may not be completely reversible
Hereditary Hyperbilirubinemia
• Increased serum bilirubin levels (hyperbilirubinemia) resulting from
• several inherited disorders can also produce jaundice. Gilbert’s
syndrome
• is a familial disorder characterized by an increased level of
unconjugated
• bilirubin that causes jaundice. Although serum bilirubin
• levels are increased, liver histology and liver function test results are
• normal, and there is no hemolysis. This syndrome affects 2% to 5
PORTAL HYPERTENSION
• Obstructed blood flow through the damaged liver results in increased
• blood pressure (portal hypertension) throughout the
• portal venous system. Although portal hypertension is commonly
• associated with hepatic cirrhosis, it can also occur with noncirrhotic
• liver disease. While splenomegaly (enlarged spleen) with
• possible hypersplenism is a common manifestation of portal hypertension,
• two major consequences of portal hypertension are
• ascites and varices.
• In ascites, fluid accumulates in the abdominal cavity. Although
• ascites is often a result of liver damage, it may also occur
• with disorders such as cancer, kidney disease, and heart failure.
• Varices are varicosities that develop from elevated pressures transmitted
• to all of the veins that drain into the portal system. They
• are prone to rupture and often are the source of massive hemorrhages
• from the upper GI tract and the rectum. In addition,
• blood clotting abnormalities, often seen in patients with severe
• liver disease, increase the likelihood of bleeding
ASCITES
• Clinical Manifestations
• Increased abdominal girth and rapid weight gain are common
• presenting symptoms of ascites. The patient may be short of
• breath and uncomfortable from the enlarged abdomen, and striae
• and distended veins may be visible over the abdominal wall. Fluid
• and electrolyte imbalances are common.
Assessment-bulging flanks in supine position
percussion /fluid wave
• Medical Management
• DIETARY MODIFICATION
• The goal of treatment for the patient with ascites is a negative
• sodium balance to reduce fluid retention. Table salt, salty foods,
• salted butter and margarine, and all ordinary canned and frozen
• foods (foods that are not specifically prepared for low-sodium diets)
• should be avoided. It may take 2 to 3 months for the patient’s taste
• buds to adjust to unsalted foods. In the meantime, the taste of unsalted
• foods can be improved by using salt substitutes such as lemon
• juice, oregano, and thyme. Commercial salt substitutes need to be
• approved by the physician because those containing ammonia
• could precipitate hepatic coma. Most salt substitutes contain potassium
BED REST
In patients with ascites, an upright posture is associated with
activation
of the renin-angiotensin-aldosterone system and sympathetic
nervous system (Porth, 2002). This results in reduced renal
glomerular filtration and sodium excretion and a decreased
response
to loop diuretics. Bed rest may be a useful therapy, especially
for patients whose condition is refractory to diuretics.
PARACENTESIS
Paracentesis is the removal of fluid (ascites) from the peritoneal
cavity through a small surgical incision or puncture made
through
the abdominal wall under sterile conditions. Ultrasound
guidance
may be indicated in some patients at high risk for bleeding
because of an abnormal coagulation profile or in those who
have
had previous abdominal surgery and who may have adhesions.
Paracentesis was once considered a routine form of treatment
for
ascites but is now performed primarily for diagnostic
examination
of ascitic fluid, for treatment of massive ascites that is resistant
to
nutritional and diuretic therapy and that is causing severe
problems
to the patient, and as a prelude to diagnostic imaging studies,
peritoneal dialysis, or surgery. A sample of the ascitic fluid may
be
sent to the laboratory for analysis. Cell count, albumin and total
protein levels, culture, and occasionally other tests are perform
ESOPHAGEAL VARICES
• Pathophysiology
• Esophageal varices are dilated, tortuous veins usually found in the
• submucosa of the lower esophagus, but they may develop higher in
• the esophagus or extend into the stomach. This condition nearly
• always is caused by portal hypertension, which in turn is due to obstruction
• of the portal venous circulation within the damaged liver.
• Because of increased obstruction of the portal vein, venous
• blood from the intestinal tract and spleen seeks an outlet through
• collateral circulation (new pathways of return to the right atrium).
• The effect is increased pressure, particularly in the vessels in the
• Clinical Manifestations
• The patient with bleeding esophageal varices may present with
• hematemesis, melena, or general deterioration in mental or physical
• status and often has a history of alcohol abuse. Signs and symptoms
of shock
Medical Management
• Bleeding from esophageal varices can quickly lead to hemorrhagic
• shock and is an emergency. This patient is critically ill,
• requiring aggressive medical care and expert nursing care, and
• is usually transferred to the intensive care unit for close monitoring
• and management
• IV fluids to replace fluid volume and electrolytes
• Blood transfusion may be required
• Catheterize to monitor urine output
PHARMACOLOGIC THERAPY
• Vasopressin (Pitressin) may be
• the initial mode of therapy because it produces constriction of the
• splanchnic arterial bed and a resulting decrease in portal pressure.
• It may be administered intravenously or by intra-arterial infusion
• Close monitoring of vital signs and intake output –vasopressin may cause
hyponatremia and have antidiuretic effect
• Vasopressin with nitroglcerine
• Somatostatin
• Propranolol –beta blocking agents decresase portal pressure
• Nitrates –lower portal pressure by decreas
BALLOON TAMPONADE
• To control hemorrhage in certain patients, balloon tamponade
• may be used. In this procedure, pressure is exerted on the cardia
• (upper orifice of the stomach) and against the bleeding varices
• by a double-balloon tamponade (Sengstaken-Blakemore tube)
• (Fig. 39-7). The tube has four openings, each with a specific purpose:
• gastric aspiration, esophageal aspiration, inflation of the
• gastric balloon, and inflation of the esophageal balloon
HEPATIC CIRRHOSIS
• Cirrhosis is a chronic disease characterized by replacement of normal
• liver tissue with diffuse fibrosis that disrupts the structure and
• function of the liver. There are three types of cirrhosis or scarring
• of the liver:
• • Alcoholic cirrhosis, in which the scar tissue characteristically
• surrounds the portal areas. This is most frequently
• due to chronic alcoholism and is the most common type
• of cirrhosis
• • Postnecrotic cirrhosis, in which there are broad bands of
• scar tissue as a late result of a previous bout of acute viral
• hepatitis.
• • Biliary cirrhosis, in which scarring occurs in the liver around
• the bile ducts. This type usually is the result of chronic biliary
• obstruction and infection (cholangitis); it is much less
• common than the other two types.
Clinical Manifestations
• Compensated (less severe)
• Intermittent mild fever
• Vascular spiders
• Palmar erythema (reddened palms)
• Unexplained epistaxis
• Ankle edema
• Vague morning indigestion
• Flatulent dyspepsia
• Abdominal pain
• Firm, enlarged liver
• Splenomegaly
Clinical manifestations
(hepatic dysfunction)
• Decompensated
• Ascites hypotension
• Jaundice sparse body hair
• Weakness
• Muscle wasting white nails
• Weight loss
• Continuous mild fever gonadal atrophy
• Clubbing of fingers
• Purpura (due to decreased platelet count)
• Spontaneous bruising
• Epistaxis
Medical Management
• The management of the patient with cirrhosis is usually based on
• the presenting symptoms. For example, antacids are prescribed to
• decrease gastric distress and minimize the possibility of GI bleeding.
• Vitamins and nutritional supplements promote healing of
• damaged liver cells and improve the general nutritional status.
• Potassium-sparing diuretics (spironolactone [Aldactone], triamterene
• [Dyrenium]) may be indicated to decrease ascites, if
• present; these diuretics are preferable to other diuretic agents because
• they minimize the fluid and electrolyte changes common
• with other agents. An adequate diet and avoidance of alcohol are
• essential. Although the fibrosis of the cirrhotic liver cannot be reversed,
• its progression may be halted or slowed by such measures.
NURSING PROCESS:
THE PATIENT WITH HEPATIC CIRRHOSIS
• Assessment
• Nursing assessment focuses on the onset of symptoms and the history
• of precipitating factors, particularly long-term alcohol abuse,
• as well as dietary intake and changes in the patient’s physical and
• mental status. The patient’s past and current patterns of alcohol
• use (duration and amount) are assessed and documented. It is also
• important to document any exposure to toxic agents encountered
• in the workplace or during recreational activities. The nurse documents
• and reports exposure to potentially hepatotoxic substances
• (medications, illicit IV/injection drugs, inhalants) or general anesthetic
• agents
NURSING DIAGNOSES
• • Activity intolerance related to fatigue, general debility, muscle
• wasting, and discomfort
• • Imbalanced nutrition, less than body requirements, related
• to chronic gastritis, decreased GI motility, and anorexia
• • Impaired skin integrity related to compromised immunologic
• status, edema, and poor nutrition
Liver Abscesses
• Two categories of liver abscess have been identified: amebic and
• pyogenic. Amebic liver abscesses are most commonly caused by
• Entamoeba histolytica. Most amebic liver abscesses occur in the
• developing countries of the tropics and subtropics because of
• poor sanitation and hygiene. Pyogenic liver abscesses are much
• less common but are more common in developed countries than
• the amebic type.
Pathophysiology
• Whenever an infection develops anywhere along the biliary or GI
tract, infecting organisms may reach the liver through the biliary
System, portal venous system, or hepatic arterial or lymphatic
system ,Most bacteria are destroyed .bacteria toxins destroy liver cells .
leucocytes migrate to the affected area .the result is an abscess cavity
full of liquid containing bacteria , dead and live leucocytes and
liquefied liver cells
Clinical Manifestations
• The clinical picture is one of sepsis with few or no localizing
• signs. Fever with chills and diaphoresis, malaise, anorexia, nausea,
• vomiting, and weight loss may occur. The patient may
• complain of dull abdominal pain and tenderness in the right
• upper quadrant of the abdomen. Hepatomegaly, jaundice, anemia,
• and pleural effusion may develop. Sepsis and shock may be
• severe and life-threatening.
Assessment and Diagnostic
Findings
• Blood cultures are obtained but may not identify the organism.
• Aspiration of the liver abscess, guided by ultrasound, CT, or MRI,
• may be performed to assist in diagnosis and to obtain cultures of
• the organism. Percutaneous drainage of pyogenic abscesses is carried
out to evacuate abscess and promote healing
• catheter may be left in place for continuous drainage; the patient
• must be instructed about its management.s material and promote
healing
Medical Management
• Treatment includes IV antibiotic therapy; the specific antibiotic
• used in treatment depends on the organism identified. Continuous
• supportive care is indicated because of the serious condition of the
• patient. Open surgical drainage may be required if antibiotic therapy
• and percutaneous drainage are ineffective.
Nursing Management
• For patients who undergo evacuation and drainage of
• the abscess, monitoring of the drainage and skin care are imperative.
• Strategies must be implemented to contain the drainage and
• to protect the patient from other sources of infection. Vital signs
• are monitored to detect changes in the patient’s physical status.
• Deterioration in vital signs or the onset of new symptoms such as
• increasing pain, which may indicate rupture or extension of the
• abscess, is reported promptly. The nurse administers IV antibiotic
• therapy as prescribed. The white blood cell count and other laboratory
• test results are monitored closely for changes consistent with
• worsening infection. The nurse prepares the patient for discharge
• by providing instruction about symptom management, signs and
• symptoms that should be reported to the physician, management
• of drainage, and the importance of taking antibiotics as prescribed.